Phase I/II trial of a dendritic cell vaccine transfected with DNA encoding melan A and gp100 for patients with metastatic melanoma.
Feb 2011 - :1476-5462 [PMID:21307889]
[Steele JC] [Rao A] [Marsden JR] [Armstrong CJ] [Berhane S] [Billingham LJ] [Graham N] [Roberts C] [Ryan G] [Uppal H] [Walker C] [Young LS] [Steven NM]